CIHR Projects

Browse 3998 CIHR-funded research projects

Search & Filter Projects
Clear All
Showing 3951-3998 of 3998 projects

PI: Ng, Sylvia

Pancreatic cancer is the most deadly solid organ tumor with a typical life expectancy of 3-6 months after diagnosis. Prognosis is poor because this malignancy is often detected too late for surgery t…

Unclear Biomedical
$367,857
Year: 2008
Cancer Research
View Details

PI: Moon, Nam S

Accumulation of hazardous mutations is responsible for cancer development. Many genes prone to mutation in cancer are evolutionarily conserved, and their homologs have been identified in different sp…

Unclear Biomedical
$538,712
Year: 2008
Cancer Research
View Details

PI: Nelson, Brad H

It has recently been shown that many ovarian cancer patients mount immune responses against their tumor. This is reflected in the fact that many ovarian tumors are densely packed with "T cells", a ty…

Unclear Biomedical
$394,059
Year: 2008
Cancer Research
View Details

PI: White, John H; Gleason, James L

The hormonal form of vitamin D, 1,25-dihydroxyvitamin D3 (1,25D) binds to the vitamin D receptor (VDR) and is a key regulator of calcium homeostasis. However, data from multiple sources, including on…

Unclear Biomedical
$352,761
Year: 2008
Cancer Research
View Details

PI: Royal, Isabelle D

Much progress has been made over the last decade in our understanding of the cellular mechanisms leading to cancer. In spite of this, cancer still remains a major cause of human death. A novel antica…

Unclear Biomedical
$643,065
Year: 2008
Cancer Research
View Details

PI: Bonni, Shirin

Controlled cell division, or proliferation, is essential for normal growth and function of the developing and adult organisms. Importantly, unchecked cell proliferation may cause increased number of …

Unclear Biomedical
$474,746
Year: 2008
Cancer Research
View Details

PI: Lilge, Lothar

Photodynamic Therapy (PDT) attained approval for various oncological indications, but only for applications in the skin or other superficial tumours such as the bladder. Particular treatments of soli…

Unclear Biomedical
$451,912
Year: 2008
Cancer Research
View Details

PI: Brown, Theodore J

Epithelial ovarian cancer is associated with a high death rate, killing more than 17,000 women each year in North America. A lack of means to detect the disease at early stages, coupled with the abse…

Unclear Biomedical
$598,992
Year: 2008
Cancer Research
View Details

PI: Andrulis, Irene L

Axillary lymph node status in breast cancer is the most important factor in predicting a patient's risk of recurrence of disease. Patients whose disease has not spread to the lymph nodes (axillary no…

Unclear Biomedical
$866,726
Year: 2008
Cancer Research
View Details

PI: Scheid, Michael P

Cancer is a disease in which cells of the body become growth deregulated. During development, cell division is normal and is controlled by signals transmitted by a class of proteins called kinases. N…

Unclear Biomedical
$322,998
Year: 2008
Cancer Research
View Details

PI: Miller, Wilson H

Although considerable progress has been made in understanding the biology of cancer, effective novel therapeutics are still urgently needed in human malignancies. We have studied the mechanism of act…

Unclear Biomedical
$851,780
Year: 2008
Cancer Research
View Details

PI: Jurisica, Igor; Oza, Amit M

Mortality rate from epithelial ovarian cancer (EOC) is higher than that of any other cancer among women in the North America, with staggering 63%. Currently, 75% of new cases are not diagnosed until …

Unclear Biomedical
$643,742
Year: 2008
Cancer Research
View Details

PI: Dacosta, Ralph S

Radiation therapy (RT) plays a significant role in cancer treatment, and has until recently been thought to be curative by mainly killing tumor cells directly by damaging their genetic material (DNA)…

Unclear Biomedical
$347,478
Year: 2008
Cancer Research
View Details

PI: Therrien, Marc

Oncogenes have the capacity to transform cells and promote cancer. They often result from specific mutations that hyper-activate or change normal gene function and thereby force a cell to engage in a…

Unclear Biomedical
$721,795
Year: 2008
Cancer Research
View Details

PI: Fradet, Yves

Bladder cancer is sixth in incidence in Canada. About 75% of initial tumors are non-muscle invasive and although treated effectively by transurethral surgery, will recur in 50-80% of cases and progre…

Unclear Biomedical
$322,690
Year: 2008
Cancer Research
View Details

PI: Minchinton, Andrew I

Hypoxic cells occur in human tumours and represent a population of cells resistant to ionizing radiation. Clinical studies in several tumour sites indicate that the effectiveness of radiotherapy is i…

Unclear Biomedical
$560,232
Year: 2008
Cancer Research
View Details

PI: Di Guglielmo, Gianni (John) M

Transforming growth factor-beta (TGFß) is a cytokine that normally acts as a tumor suppressor. However, in lung tumors it switches roles and aides tumor cells to become metastatic. We will investigat…

Unclear Biomedical
$633,015
Year: 2008
Cancer Research
View Details

PI: Xiao, Wei

It is now well accepted that cancer is caused by DNA alterations and mutations in a group of cancer related genes. DNA repair plays an important role in protecting cells from such DNA damage and muta…

Unclear Biomedical
$492,133
Year: 2008
Cancer Research
View Details

PI: Lepage, Martin

Pharmacokinetic modeling is used to characterize the environment of tumours. First, images are acquired using either magnetic resonance imaging (MRI) or positron emission tomography (PET), a compound…

Unclear Biomedical
$306,240
Year: 2008
Cancer Research
View Details

PI: Ramotar, Dindial

Project summary: Reactive oxygen species are highly unstable molecules and are produced, e.g., by mitochondrial respiration and activated neutrophils. These reactive oxygen species can attack and des…

Other Neurology Clinical
$355,206
Year: 2008
Cancer Research
View Details

PI: Couture, Jean-François

Cells are composed of millions of molecules working symbiotically to maintain a cellular balance. If broken, this fragile orchestration of events could potentially lead to chemical alterations of the…

Other Cancer Biomedical
$525,620
Year: 2008
Cancer Research
View Details

PI: Naus, Christian C

Gap junctions are traditionally made up of connexins subunits that form a pore allowing communication to occur between two adjacent cells. Recently a new family of gap junction-like protein called pa…

Other Cancer Biomedical
$645,690
Year: 2008
Cancer Research
View Details

PI: Guillemette, Chantal

Glucuronosyltransferase (UGT) enzymes are responsible for the glucuronidation metabolic pathway and play an essential role in the elimination and detoxification of a large diversity of drugs from all…

Other Cancer Biomedical
$810,494
Year: 2008
Cancer Research
View Details

PI: Graham, Charles H

Our immune system can eliminate cancer as it develops. However, due to reasons not fully understood, some cancers develop ways to avoid elimination by 'killer' cells of our immune system called natur…

Other Cancer Biomedical
$529,669
Year: 2008
Cancer Research
View Details

PI: Chevrette, Mario

Numerous genetic changes occur as prostate cancer becomes more aggressive. We have shown that one such change is the loss of expression of CD9, a protein which is also lost in other human cancers. Re…

Other Cancer Biomedical
$313,083
Year: 2008
Cancer Research
View Details

PI: Zacksenhaus, Eldad

The tumor suppressor pRb is lost by mutations or functional inactivation in most, if not all, human cancers. The prevailing view is pRb controls cell proliferation and survival as well as differentia…

Other Cancer Biomedical
$488,674
Year: 2008
Cancer Research
View Details

PI: Frappier, Lori D

Human cell nuclei contain several structures referred to as PML bodies because PML (promyelocytic leukemia) proteins form the basis of these structures and alterations to the PML proteins result in l…

Other Cancer Biomedical
$569,660
Year: 2008
Cancer Research
View Details

PI: Meloche, Sylvain

MAP kinases are a family of enzymes that play important roles in the control of cell proliferation and survival. Accumulating evidence suggests that these enzymes may be implicated in the pathogenesi…

Other Oncology Biomedical
$888,180
Year: 2008
Cancer Research
View Details

PI: Fenster, Aaron

With the exception of non-melanomatous skin cancer, prostate cancer is the most commonly diagnosed cancer and the third highest cause of cancer related mortality in men. It is found at autopsy in 40%…

Other Oncology Biomedical
$631,813
Year: 2008
Cancer Research
View Details

PI: Bedell, Barry J

While significant advances have recently been made in the treatment of a variety of cancers, brain tumours called gliomas have generally remained resistant to current drugs. As such, there currently …

Other Oncology Biomedical
$300,000
Year: 2008
Cancer Research
View Details

PI: Wang, Yuzhuo

Most deaths from prostate cancer (PCa) are due to metastases (cancer spread) in a form that is highly resistant to conventional therapies. There is an urgent need for more effective therapy to improv…

Other Oncology Biomedical
$541,348
Year: 2008
Cancer Research
View Details

PI: Postovit, Lynne-Marie

Rapidly growing tumours contain many areas of low oxygen (hypoxia), and the presence of these hypoxic regions is associated with cancer metastasis and a poor clinical outcome. In a manner similar to …

Other Cancer Biomedical
$300,000
Year: 2008
Cancer Research
View Details

PI: Kislinger, Thomas; Medin, Jeffrey A

Prostate cancer is the most common cancer among North American men and is in general treated by surgery, radiation therapy or chemotherapy. Cell-surface membrane proteins comprise more than half of t…

Other Cancer Biomedical
$383,699
Year: 2008
Cancer Research
View Details

PI: Rousseau, Marie-Claude; Nicolau, Belinda F

Previous studies have shown that certain types of cancer begin as lesions appearing in different parts of the body. This study aims to investigate these lesions in the mouth and throat to determine w…

Observational Oncology Social / Cultural / Envi…
$306,721
Year: 2008
Cancer Research
View Details

PI: Jones, Russell G

Cell division is a highly regulated process. The ability of a cell to successfully grow and divide partly depends on the cell having enough energy and building blocks to complete the task. Cancer is …

Other Oncology Biomedical
$533,730
Year: 2008
Cancer Research
View Details

PI: Jones, Russell G

Cell division is a highly regulated process. The ability of a cell to successfully grow and divide partly depends on the cell having enough energy and building blocks to complete the task. Cancer is …

Other Oncology Biomedical
$300,000
Year: 2008
Cancer Research
View Details

PI: Young, James D

A number of nucleoside analogs have anticancer activities and are either in current clinical use or in various stages of preclinical evaluation. Since the pharmacological targets of nucleoside drugs …

Other Oncology Biomedical
$751,305
Year: 2008
Cancer Research
View Details

PI: Li, Gang

Cutaneous malignant melanoma is a life-threatening skin cancer due to its high metastatic potential. The mechanism behind the high invasive property and metastatic potential of melanoma is still inco…

Other Oncology Biomedical
$569,275
Year: 2008
Cancer Research
View Details

PI: Mai, Sabine

We have previously shown that the structural order of the cell is changed when cells become tumor cells. To document this, we have studied one central component in the cell that is called the nucleus…

Other Oncology Biomedical
$388,829
Year: 2008
Cancer Research
View Details

PI: Litchfield, David W

The recent success of Gleevec (imatinib) which targets the BCR-Abl protein kinase for the treatment of chronic myelogenous leukemia provides proof-of-principle for molecular-targeted therapy directed…

Other Oncology Biomedical
$622,698
Year: 2008
Cancer Research
View Details

PI: Branton, Philip E

For some time we have used human adenoviruses as models to understand the molecular basis of cancer as such studies have provided many critical insights into processes of importance for cancer. In th…

Other Oncology Biomedical
$720,706
Year: 2008
Cancer Research
View Details

PI: Brundage, Michael D

Radiotherapy is an important form of treatment for cancer patients and has been shown to be useful in about 50% of patients with cancer. It can be used alone or in combination with chemotherapy or su…

Other Oncology Health systems / services
$249,374
Year: 2008
Cancer Research
View Details

PI: Marshall, Jean S

A number of bacterial and viral products have been shown to reduce tumor growth in models of cancer and in clincal trials, however we have a poor understadning of how these work. Mast cells are immun…

Other Oncology Biomedical
$781,265
Year: 2008
Cancer Research
View Details

PI: Spaner, David E

Chemotherapy does not cure most cancers. However, the results with chemotherapy may be improved with treatments that increase the ability of the immune system to kill cancer cells (or immunotherapy).…

Other Oncology Biomedical
$380,709
Year: 2008
Cancer Research
View Details

PI: Richard, Stéphane

The detection and repair of DNA damage are vital for cell viability. DNA repair defects lead to DNA translocations, deletions/ mutations, chromosome breakage leading to 'genomic instability' and canc…

Basic_Research Oncology Biomedical
$877,100
Year: 2008
Cancer Research
View Details

PI: Houry, Walid A

Hsp90 is a ubiquitous molecular chaperone that is found in eubacteria and all branches of eukarya. It plays a central role in cellular signaling since it is essential for maintaining the activity of …

Trial Psychiatry Biomedical
$677,895
Year: 2008
Cancer Research
View Details

PI: Rathee, Satyapal; Fallone, Biagio G

Nearly half of the cancer patients will receive radiation therapy for their treatment. Image guided radiotherapy promises to precisely align the diseased volume with the radiation beams in real time,…

Other Infectious_Disease Biomedical
$263,007
Year: 2008
Cancer Research
View Details

PI: Brown, Grant W

Before a cell can grow and divide it must duplicate its DNA. In this way, when a cell divides to form two daughter cells, each of the daughters will receive the full complement of genes required for …

Trial Critical_Care Biomedical
$623,515
Year: 2008
Cancer Research
View Details